Wells Fargo’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,251
| Closed | -$17K | – | 7289 |
|
|
2024
Q3 | $17K | Sell |
29,251
-1
| -0% | -$1 | ﹤0.01% | 5684 |
|
|
2024
Q2 | $18.1K | Sell |
29,252
-11,846
| -29% | -$10K | ﹤0.01% | 5614 |
|
|
2024
Q1 | $106K | Sell |
41,098
-2,694
| -6% | -$6.58K | ﹤0.01% | 4859 |
|
|
2023
Q4 | $89.3K | Buy |
43,792
+17,786
| +68% | +$32.5K | ﹤0.01% | 4974 |
|
|
2023
Q3 | $44.7K | Sell |
26,006
-18,991
| -42% | -$33.7K | ﹤0.01% | 5239 |
|
|
2023
Q2 | $87.7K | Buy |
44,997
+32,928
| +273% | +$77.1K | ﹤0.01% | 5125 |
|
|
2023
Q1 | $33.6K | Buy |
12,069
+8
| +0.1% | +$23 | ﹤0.01% | 5384 |
|
|
2022
Q4 | $41.6K | Buy |
12,061
+75
| +0.6% | +$214 | ﹤0.01% | 4954 |
|
|
2022
Q3 | $31K | Buy |
11,986
+41
| +0.3% | +$131 | ﹤0.01% | 5178 |
|
|
2022
Q2 | $29K | Sell |
11,945
-68,297
| -85% | -$179K | ﹤0.01% | 5280 |
|
|
2022
Q1 | $331K | Sell |
80,242
-50,453
| -39% | -$267K | ﹤0.01% | 4695 |
|
|
2021
Q4 | $1.68M | Sell |
130,695
-88,361
| -40% | -$978K | ﹤0.01% | 3665 |
|
|
2021
Q3 | $2.37M | Buy |
219,056
+190,039
| +655% | +$1.73M | ﹤0.01% | 3514 |
|
|
2021
Q2 | $265K | Sell |
29,017
-7,167
| -20% | -$66.3K | ﹤0.01% | 4912 |
|
|
2021
Q1 | $341K | Buy |
36,184
+3,142
| +10% | +$43.3K | ﹤0.01% | 4895 |
|
|
2020
Q4 | $130K | Buy |
33,042
+15,053
| +84% | +$45.5K | ﹤0.01% | 5260 |
|
|
2020
Q3 | $48K | Sell |
17,989
-5,844
| -25% | -$21.7K | ﹤0.01% | 5529 |
|
|
2020
Q2 | $158K | Sell |
23,833
-3,374
| -12% | -$22.7K | ﹤0.01% | 5028 |
|
|
2020
Q1 | $158K | Buy |
27,207
+3,455
| +15% | +$29K | ﹤0.01% | 4822 |
|
|
2019
Q4 | $213K | Sell |
23,752
-17,187
| -42% | -$143K | ﹤0.01% | 4917 |
|
|
2019
Q3 | $354K | Buy |
40,939
+6,968
| +21% | +$70.4K | ﹤0.01% | 4605 |
|
|
2019
Q2 | $379K | Buy |
33,971
+26,695
| +367% | +$305K | ﹤0.01% | 4577 |
|
|
2019
Q1 | $97K | Sell |
7,276
-19,595
| -73% | -$262K | ﹤0.01% | 5136 |
|
|
2018
Q4 | $416K | Sell |
26,871
-13,724
| -34% | -$262K | ﹤0.01% | 4446 |
|
|
2018
Q3 | $578K | Buy |
+40,595
| New | +$578K | ﹤0.01% | 4333 |
|
Other funds holding GRTS
Wells Fargo's GRTS Position: Q4 2024 in Review
Wells Fargo sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 29,251 shares — an estimated $17K sold.
Wells Fargo first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $2.37M in Q3 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Wells Fargo reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 29,251 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $17K.
- Wells Fargo first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
- Wells Fargo's Gritstone bio, Inc. Common Stock position peaked at $2.37M in Q3 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.